CDNA Q3 2018 Earnings — CareDx, Inc Revenue & Financial Results | Market Cap Arena

CDNACareDx, Inc

$858M

Q3 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$21M+73.8% YoY

Gross Profit

$12M58.0% margin

Operating Income

-$3M-12.8% margin

Net Income

-$20M-94.3% margin

EPS (Diluted)

$-0.54

QoQ Revenue Growth

+18.9%

Cash Flow

Operating Cash Flow

$399,000

Free Cash Flow

-$215,000

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$91M

Total Liabilities

$47M

Stockholders' Equity

$44M

Cash & Equivalents

$26M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$12M	+73.8%
Gross Profit	$12M	$7M	+76.1%
Operating Income	-$3M	-$4M	+29.6%
Net Income	-$20M	-$14M	-40.0%

Revenue Segments

Service

$17M80%

Product

$4M20%

License And Other

$114,0001%

Geographic Segments

UNITED STATES

$37M87%

Europe

$4M10%

Rest Of The World

$1M3%